Maze Therapeutics (MAZE) Stock Chart & Stock Price History $13.49 +0.26 (+1.97%) As of 08/22/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock Maze Therapeutics Stock Price Performance The Maze Therapeutics (MAZE) stock chart highlights key performance trends across multiple timeframes. In the past month, the stock has decreased 19.80%, reflecting recent market activity. As of the latest close, Maze Therapeutics traded at $13.49 with a market cap of $591.54 million and volume of 263,956 shares. Receive MAZE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Maze Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+0.07%1 Month Performance-19.80%3 Month Performance+31.23% MAZE Stock Chart for Monday, August, 25, 2025 MAZE Chart by TradingView Maze Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/22/2025$13.23$13.49+1.97%$14.02$13.30263,956 shs$591.54 million08/21/2025$13.48$13.23-1.85%$13.93$13.00192,252 shs$580.14 million08/20/2025$13.45$13.48+0.22%$14.01$13.24476,471 shs$591.11 million08/19/2025$13.35$13.45+0.75%$13.75$12.81214,992 shs$589.78 million08/18/2025$13.50$13.35-1.11%$13.92$13.20140,316 shs$585.40 million08/15/2025$13.35$13.50+1.12%$13.58$12.86136,553 shs$591.98 million08/14/2025$13.60$13.35-1.84%$13.59$13.00101,096 shs$584.69 million08/13/2025$13.74$13.60-1.02%$14.56$13.16299,055 shs$595.68 million08/12/2025$13.47$13.74+2.00%$13.85$13.2299,702 shs$601.81 million08/11/2025$13.14$13.47+2.51%$13.86$13.07113,650 shs$589.95 million Get the Latest News and Ratings for MAZE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Maze Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 08/08/2025$13.32$13.14-1.35%$13.86$12.9572,288 shs$575.53 million08/07/2025$14.25$13.32-6.53%$14.17$12.90156,197 shs$583.38 million08/06/2025$14.51$14.25-1.79%$14.58$13.71104,359 shs$624.15 million08/05/2025$15.25$14.51-4.85%$15.85$13.87309,979 shs$635.54 million08/04/2025$14.90$15.25+2.35%$15.74$13.75190,866 shs$667.90 million08/01/2025$14.75$14.90+1.02%$15.38$13.82243,255 shs$652.58 million07/31/2025$15.50$14.75-4.84%$15.68$14.20270,005 shs$646.05 million07/30/2025$15.74$15.50-1.52%$16.54$15.30114,700 shs$678.90 million07/29/2025$16.36$15.74-3.79%$16.48$15.00117,838 shs$689.37 million07/28/2025$16.82$16.36-2.73%$17.38$16.1846,422 shs$716.57 million07/25/2025$16.45$16.82+2.25%$17.10$16.1451,167 shs$736.72 million07/24/2025$17.64$16.45-6.75%$18.40$16.1185,863 shs$720.51 million Related Companies Centessa Pharmaceuticals Stock Chart Denali Therapeutics Stock Chart Agios Pharmaceuticals Stock Chart ImmunityBio Stock Chart IDEAYA Biosciences Stock Chart Harmony Biosciences Stock Chart Recursion Pharmaceuticals Stock Chart Ocular Therapeutix Stock Chart Disc Medicine Stock Chart Belite Bio Stock Chart Receive MAZE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Maze Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MAZE) was last updated on 8/25/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Maze Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Maze Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access